[
{
"numtree":"1.0.0.0",
"id":"1",
"nametree":"Introduction",
"tocnametree":"Overview",
"htmlpage":"ENAS5571_1.0.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.0.0.0",
"id":"2",
"nametree":"Hypertension/Blood Pressure Control",
"tocnametree":"Hypertension/Blood Pressure Control",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.1.0.0",
"id":"3",
"nametree":"Overview",
"tocnametree":"Overview",
"htmlpage":"ENAS5571_2.1.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.2.0.0",
"id":"4",
"nametree":"Screening and Diagnosis",
"tocnametree":"Screening and Diagnosis",
"htmlpage":"ENAS5571_2.2.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.3.0.0",
"id":"5",
"nametree":"Treatment Goals",
"tocnametree":"Treatment Goals",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.3.1.0",
"id":"6",
"nametree":"Recommendations",
"tocnametree":"Recommendations",
"htmlpage":"ENAS5571_2.3.1.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.3.2.0",
"id":"7",
"nametree":"RCT of Intensive VS. Standard BP control",
"tocnametree":"RCT of Intensive VS. Standard BP control",
"htmlpage":"ENAS5571_2.3.2.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.3.3.0",
"id":"8",
"nametree":"Meta-analyses of Trials",
"tocnametree":"Meta-analyses of Trials",
"htmlpage":"ENAS5571_2.3.3.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.3.4.0",
"id":"9",
"nametree":"Individualization of Treatment Targets",
"tocnametree":"Individualization of Treatment Targets",
"htmlpage":"ENAS5571_2.3.4.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.3.5.0",
"id":"10",
"nametree":"Pregnancy & Anti-HTN Medications",
"tocnametree":"Pregnancy & Anti-HTN Medications",
"htmlpage":"ENAS5571_2.3.5.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.0.0",
"id":"11",
"nametree":"Treatment Strategies",
"tocnametree":"Treatment Strategies",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.1.0",
"id":"12",
"nametree":"Lifestyle Intervention",
"tocnametree":"Lifestyle Intervention",
"htmlpage":"ENAS5571_2.4.1.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.2.0",
"id":"13",
"nametree":"Pharmacologic Interventions",
"tocnametree":"Pharmacologic Interventions",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.2.1",
"id":"14",
"nametree":"Recommendations",
"tocnametree":"Recommendations",
"htmlpage":"ENAS5571_2.4.2.1",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.2.2",
"id":"15",
"nametree":"Initial Number of Antihypertensives",
"tocnametree":"Initial Number of Antihypertensives",
"htmlpage":"ENAS5571_2.4.2.2",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.2.3",
"id":"16",
"nametree":"Classes of Antihypertensives",
"tocnametree":"Classes of Antihypertensives",
"htmlpage":"ENAS5571_2.4.2.3",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.2.4",
"id":"17",
"nametree":"Multiple-Drug Therapy",
"tocnametree":"Multiple-Drug Therapy",
"htmlpage":"ENAS5571_2.4.2.4",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.2.5",
"id":"18",
"nametree":"Bedtime Dosing",
"tocnametree":"Bedtime Dosing",
"htmlpage":"ENAS5571_2.4.2.5",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.3.0",
"id":"19",
"nametree":"Hyperkalemia and AKI",
"tocnametree":"Hyperkalemia and AKI",
"htmlpage":"ENAS5571_2.4.3.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"2.4.4.0",
"id":"20",
"nametree":"Resistant Hypertension",
"tocnametree":"Resistant Hypertension",
"htmlpage":"ENAS5571_2.4.4.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.0.0.0",
"id":"21",
"nametree":"Lipid Management",
"tocnametree":"Lipid Management",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.1.0.0",
"id":"22",
"nametree":"Lifestyle Intervention",
"tocnametree":"Lifestyle Intervention",
"htmlpage":"ENAS5571_3.1.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.2.0.0",
"id":"23",
"nametree":"Therapy & Monitoring w/ Lipid Panel",
"tocnametree":"Therapy & Monitoring w/ Lipid Panel",
"htmlpage":"ENAS5571_3.2.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.3.0.0",
"id":"24",
"nametree":"Statin Treatment",
"tocnametree":"Statin Treatment",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.3.1.0",
"id":"25",
"nametree":"Recommendations",
"tocnametree":"Recommendations",
"htmlpage":"ENAS5571_3.3.1.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.3.2.0",
"id":"26",
"nametree":"Initiating Statin Therapy Based on Risk",
"tocnametree":"Initiating Statin Therapy Based on Risk",
"htmlpage":"ENAS5571_3.3.2.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.3.3.0",
"id":"27",
"nametree":"Primary Prevention (Patients w/o ASCVD)",
"tocnametree":"Primary Prevention (Patients w/o ASCVD)",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.3.3.1",
"id":"28",
"nametree":"Age >40 Years and older",
"tocnametree":"Age >40 Years and older",
"htmlpage":"ENAS5571_3.3.3.1",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.3.3.2",
"id":"29",
"nametree":"Age <40 Years and/or Type 1 Diabetes",
"tocnametree":"Age <40 Years and/or Type 1 Diabetes",
"htmlpage":"ENAS5571_3.3.3.2",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.3.4.0",
"id":"30",
"nametree":"Secondary Preventions (Patients w/ ASCVD)",
"tocnametree":"Secondary Preventions (Patients w/ ASCVD)",
"htmlpage":"ENAS5571_3.3.4.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.4.0.0",
"id":"31",
"nametree":"Combination Therapy for LDL Cholesterol Lowering",
"tocnametree":"Combination Therapy for LDL Cholesterol Lowering",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.4.1.0",
"id":"32",
"nametree":"Statins and Ezetimibe",
"tocnametree":"Statins and Ezetimibe",
"htmlpage":"ENAS5571_3.4.1.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.4.2.0",
"id":"33",
"nametree":"Statins and PCSK9 Inhibitors",
"tocnametree":"Statins and PCSK9 Inhibitors",
"htmlpage":"ENAS5571_3.4.2.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.5.0.0",
"id":"34",
"nametree":"Tx of Other Lipoprotein Fractions or Targets",
"tocnametree":"Tx of Other Lipoprotein Fractions or Targets",
"htmlpage":"ENAS5571_3.5.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.6.0.0",
"id":"35",
"nametree":"Other Combination Therapy",
"tocnametree":"Other Combination Therapy",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.6.1.0",
"id":"36",
"nametree":"Recommendations",
"tocnametree":"Recommendations",
"htmlpage":"ENAS5571_3.6.1.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.6.2.0",
"id":"37",
"nametree":"Statin and Fibrate",
"tocnametree":"Statin and Fibrate",
"htmlpage":"ENAS5571_3.6.2.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.6.3.0",
"id":"38",
"nametree":"Statin and Niacin",
"tocnametree":"Statin and Niacin",
"htmlpage":"ENAS5571_3.6.3.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.7.0.0",
"id":"39",
"nametree":"Diabetes With Statin Use",
"tocnametree":"Diabetes With Statin Use",
"htmlpage":"ENAS5571_3.7.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"3.8.0.0",
"id":"40",
"nametree":"Lipid-Lowering Agents and Cognitive Function",
"tocnametree":"Lipid-Lowering Agents and Cognitive Function",
"htmlpage":"ENAS5571_3.8.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.0.0.0",
"id":"41",
"nametree":"Antiplatelet Agents",
"tocnametree":"Antiplatelet Agents",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.1.0.0",
"id":"42",
"nametree":"Recommendations",
"tocnametree":"Recommendations",
"htmlpage":"ENAS5571_4.1.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.2.0.0",
"id":"43",
"nametree":"Risk Reduction",
"tocnametree":"Risk Reduction",
"htmlpage":"ENAS5571_4.2.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.3.0.0",
"id":"44",
"nametree":"Treatment Considerations",
"tocnametree":"Treatment Considerations",
"htmlpage":"ENAS5571_4.3.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.4.0.0",
"id":"45",
"nametree":"Aspirin Use in People <50 Years of Age",
"tocnametree":"Aspirin Use in People <50 Years of Age",
"htmlpage":"ENAS5571_4.4.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.5.0.0",
"id":"46",
"nametree":"Aspirin Dosing",
"tocnametree":"Aspirin Dosing",
"htmlpage":"ENAS5571_4.5.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"4.6.0.0",
"id":"47",
"nametree":"Indications for P2Y12 Use",
"tocnametree":"Indications for P2Y12 Use",
"htmlpage":"ENAS5571_4.6.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"5.0.0.0",
"id":"48",
"nametree":"Cardiovascular Disease",
"tocnametree":"Cardiovascular Disease",
"htmlpage":"null",
"haspdf":false,
"emailContent":false
},
{
"numtree":"5.1.0.0",
"id":"49",
"nametree":"Recommendations",
"tocnametree":"Recommendations",
"htmlpage":"ENAS5571_5.1.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"5.2.0.0",
"id":"50",
"nametree":"Cardiac Testing",
"tocnametree":"Cardiac Testing",
"htmlpage":"ENAS5571_5.2.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"5.3.0.0",
"id":"51",
"nametree":"Screening Asymptomatic Patients",
"tocnametree":"Screening Asymptomatic Patients",
"htmlpage":"ENAS5571_5.3.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"5.4.0.0",
"id":"52",
"nametree":"Lifestyle and Pharm. Interventions",
"tocnametree":"Lifestyle and Pharm. Interventions",
"htmlpage":"ENAS5571_5.4.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"5.5.0.0",
"id":"53",
"nametree":"Antihyperglycemics Tx and CV Outcomes",
"tocnametree":"Antihyperglycemics Tx and CV Outcomes",
"htmlpage":"ENAS5571_5.5.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"5.6.0.0",
"id":"54",
"nametree":"Antihyperglycemic Tx & Heart Failure",
"tocnametree":"Antihyperglycemic Tx & Heart Failure",
"htmlpage":"ENAS5571_5.6.0.0",
"haspdf":false,
"emailContent":false
},
{
"numtree":"6.0.0.0",
"id":"55",
"nametree":"References",
"tocnametree":"References",
"htmlpage":"ENAS5571_6.0.0.0",
"haspdf":false,
"emailContent":false
}
]